Snibe announced on 16th July that it has received the CE mark for the fully automated quantitative serology test for detecting IgG antibodies against SARS-CoV-2 S-RBD (the receptor-binding domain of S protein). Now the new tests are ready to ship to worldwide and available to come into service.
From Feb. 3rd to 6th, Snibe brings the latest product SATLAS-TCA to Medlab Middle East with booth NO.: Z5.C20. in Dubai, United Arab Emirates, one of the largest and most influential medical exhibitions across the world, attracting more than 25,800 professional visitors, providing a great platform for all to share and communicate the recent technology available in the IVD, and medical laboratory market.
Usamos cookies para brindarle la mejor experiencia en línea. Al utilizar nuestro sitio web, acepta nuestro uso de cookies de acuerdo con nuestra política de cookies.